pyrrolidine dithiocarbamate has been researched along with Brain Swelling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Huang, W; Shan, W; Wang, Z; Wintermark, M; Zuo, Z | 1 |
| Wei, J; Xiao, GM | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Brain Swelling
| Article | Year |
|---|---|
Early administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke.
Topics: Animals; Brain Edema; Brain Infarction; Cerebral Hemorrhage; Cytokines; Drug Synergism; Fibrinolytic Agents; Intracranial Embolism; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Stroke; Thiocarbamates; Tissue Plasminogen Activator | 2018 |
Effects of beta-Aescin on the expression of nuclear factor-kappaB and tumor necrosis factor-alpha after traumatic brain injury in rats.
Topics: Animals; Body Water; Brain Edema; Brain Injuries; Escin; NF-kappa B; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiocarbamates; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |